TP53 and endometrial cancer: This study focuses on the expression of IL4I1 in tumors and its mechanism of affecting tumor progression through the regulation of the tumor microenvironment, especially its expression in P53 mutant endometrial cancer and its correlation with prognosis, aiming to provide a theoretical basis for future treatment strategies.